DermTech Expands Telehealth Application, DermTech Connect, Across 44 States | Business

LA JOLLA, Calif.–(Organization WIRE)–Apr 26, 2022–

DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive pores and skin genomics platform, introduced currently the growth of accessibility to its telehealth application, DermTech Hook up, from 8 states to 44 states, encompassing somewhere around 95% of the U.S. population. The mobile app presents enhanced access to an independent dermatologist, allowing buyers to decide on when to have a mole evaluated by a skin doctor without a excursion to a doctor’s office.

People applying DermTech Connect can take a photograph of a mole and post the image to an unbiased skin doctor for evaluation for a minimal-expense session payment. A customized suggestion from the dermatologist can be securely accessed by the affected individual, ordinarily in 48 several hours. If warranted, the skin doctor may perhaps buy the DermTech Melanoma Check for the individual. The proprietary check employs DermTech’s Good Stickers™ to non-invasively and painlessly lift pores and skin cells from the area of the skin, which are then sent to DermTech’s laboratory to be examined for the existence of genomic markers related with melanoma. A affected individual sample is self-collected with virtual supervision by qualified, accredited personnel. Melanoma is one particular of the most intense and deadliest kinds of skin most cancers, and early detection is essential to make certain bigger survivability costs.

“DermTech Link aligns with our mission to make early melanoma detection as uncomplicated and handy as feasible,” stated John Dobak, M.D., CEO of DermTech. “Teledermatology is a fast growing region of telehealth and we consider quick-to-use apps like DermTech Connect will assist boost obtain to dermatologic care. With the application, clients can submit a image of a suspicious mole typically in as very little as five minutes, as a substitute of having to hold out weeks or, in many instances, months for an in-person appointment.”

DermTech Connect is now out there in all states except Arkansas, Delaware, Idaho, Minnesota, New Hampshire, Vermont and the District of Columbia.

The DermTech Link app can be downloaded from the Apple and Android application suppliers. To find out a lot more about DermTech, pay a visit to https://dermtech.com/.

About DermTech:

DermTech is a major genomics business in dermatology and is producing a new group of medicine, precision dermatology, enabled by its non-invasive pores and skin genomics platform. DermTech’s mission is to strengthen the life of thousands and thousands by providing non-invasive precision dermatology methods that allow individualized treatment. DermTech provides genomic evaluation of pores and skin samples collected non-invasively making use of our Clever Stickers TM. DermTech marketplaces and develops products that aid the early detection of pores and skin cancers and is acquiring products and solutions that assess inflammatory conditions and customise drug treatment options. For further data, remember to visit DermTech.com.

Ahead-Wanting Statements:

This press launch contains “forward-looking statements” in just the meaning of the “safe harbor” provisions of the Personal Securities Litigation Reform Act of 1995. The anticipations, estimates, and projections of DermTech might differ from its actual outcomes and consequently, you must not depend on these ahead-seeking statements as predictions of long run activities. Phrases these kinds of as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and identical expressions are supposed to recognize these forward-seeking statements. These forward-on the lookout statements involve, devoid of limitation, anticipations and evaluations with respect to: the overall performance, affected person gains, advantages to exploration companions and collaborators, price-effectiveness, commercialization and adoption of DermTech’s solutions and providers and the market place opportunity for these items, and DermTech’s capacity to broaden its product and services offerings and build pipeline products and solutions. These ahead-on the lookout statements entail major risks and uncertainties that could bring about the actual final results to vary materially from the anticipated effects. Most of these things are exterior of the handle of DermTech and are hard to predict. Factors that may possibly lead to this kind of dissimilarities contain, but are not restricted to: (1) the result of any authorized proceedings that may perhaps be instituted in opposition to DermTech (2) DermTech’s potential to obtain additional funding to build and current market its merchandise and products and services (3) the existence of favorable or unfavorable scientific tips for DermTech’s assessments (4) the reimbursement of DermTech’s assessments by Medicare and private payors (5) the ability of people or healthcare companies to obtain coverage of or adequate reimbursement for DermTech’s items (6) DermTech’s skill to improve, take care of development and retain its key employees (7) modifications in applicable legislation or regulations (8) the sector adoption and demand for DermTech’s products and solutions together with the risk that DermTech may possibly be adversely afflicted by other economic, business, and/or aggressive elements and (9) other pitfalls and uncertainties included in (x) the “Risk Factors” section of the most current Yearly Report on Kind 10-K filed by DermTech with the Securities and Exchange Fee (the “SEC”), and (y) other files submitted or to be submitted by DermTech with the SEC, which include subsequently submitted experiences. DermTech cautions that the foregoing checklist of factors is not exclusive. You should really not put undue reliance upon any forward-seeking statements, which speak only as of the day built. DermTech does not undertake or settle for any obligation or enterprise to launch publicly any updates or revisions to any ahead-wanting statements to reflect any change in its anticipations or any adjust in activities, situations, or situations on which any these kinds of statement is dependent.

Watch supply variation on businesswire.com:https://www.businesswire.com/news/house/20220426005541/en/

Get in touch with: Steve Kunszabo

(858) 291-1647

[email protected]

Search phrase: UNITED STATES NORTH The united states CALIFORNIA

Marketplace Keyword: ONCOLOGY Overall health Technological know-how TELECOMMUNICATIONS Computer software Normal Well being

Source: DermTech, Inc.

Copyright Business enterprise Wire 2022.

PUB: 04/26/2022 04:30 PM/DISC: 04/26/2022 04:32 PM

http://www.businesswire.com/information/residence/20220426005541/en